Homems

  • NICE rejects Ocrevus for PPMS, citing cost concerns

    • July 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New mobile app can help MS patients manage their disease better

    • June 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Oromucosal Cannabinoid Spray reduces pain in MS patients, study finds

    • June 26, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NICE approves Ocrevus in RRMS but with certain conditions

    • June 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Phase 1 trial announced for a potential MS drug RTA 1701

    • June 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Latest data on Ublituximab Ph 2 study in MS patients announced at EAN

    • June 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Additional Cladribine data reinforces efficacy in RMS patients

    • June 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roche announces long term disability data for Ocrevus in PPMS patients

    • June 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Biogen launches Aby App for Multiple Sclerosis patients

    • June 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Atrophied Brain Lesion Volume could be a new biomarker for Progressive MS, study suggests

    • June 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more